Literature DB >> 18270656

A case of factor X (FX) deficiency due to novel mutation V196M, FX Hofu.

Kenji Shinohara1, Mayumi Adachi, Kumiko Matsui, Kazuhiro Matsuda, Satomi Nagaya, Eriko Morishita.   

Abstract

The patient, a 20-year-old male, was found to have a slightly prolonged prothrombin time (PT). No episodes of bleeding were noted. The measurement of coagulation factors revealed that the level of factor X (FX) activity was solely deficient, 51% (normal range: 70-130% ), and that of FX antigen was 100%. Analysis of the entire FX gene revealed the novel missense mutation of GTG to ATG, resulting in the substitution of the 196th amino acid valine --> methionine. The mother and younger brother had a normal PT time and expressed no episode of bleeding. The mother exhibited a normal level of FX activity and antigen; however the younger brother showed a slight decrease in both the parameters. This mutation was not observed in the mother and younger brother. Polymorphism is not observed at this point in healthy persons. The present novel FX mutation was named FX Hofu.

Entities:  

Mesh:

Year:  2008        PMID: 18270656     DOI: 10.1007/s12185-008-0035-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  9 in total

Review 1.  Inherited factor X deficiency: molecular genetics and pathophysiology.

Authors:  D N Cooper; D S Millar; A Wacey; S Pemberton; E G Tuddenham
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

2.  Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene.

Authors:  F H Herrmann; G Auerswald; A Ruiz-Saez; M Navarrete; H Pollmann; S Lopaciuk; A Batorova; K Wulff
Journal:  Haemophilia       Date:  2006-09       Impact factor: 4.287

3.  Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C.

Authors:  S P Leytus; D C Foster; K Kurachi; E W Davie
Journal:  Biochemistry       Date:  1986-09-09       Impact factor: 3.162

Review 4.  The molecular basis of blood coagulation.

Authors:  B Furie; B C Furie
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

5.  Factor X Nagoya 1 and Nagoya 2: a CRM- factor X deficiency and a dysfunctional CRM+ factor X deficiency characterized by substitution of Arg306 by Cys and of Gly366 by Ser, respectively.

Authors:  T Miyata; T Kojima; K Suzuki; H Umeyama; T Yamazaki; T Kamiya; H Toyoda; H Kato
Journal:  Thromb Haemost       Date:  1998-03       Impact factor: 5.249

6.  One missense mutation in the factor X gene causing factor X deficiency--factor X Kanazawa.

Authors:  E Morishita; K Yamaguchi; H Asakura; M Saito; M Yamazaki; Y Ontachi; T Mizutani; M Kato; S Nakao
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

7.  Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency.

Authors:  Flora Peyvandi; Marzia Menegatti; Elena Santagostino; Sepideh Akhavan; James Uprichard; David J Perry; Stephen J Perkins; Pier M Mannucci
Journal:  Br J Haematol       Date:  2002-06       Impact factor: 6.998

Review 8.  Factor X deficiency.

Authors:  James Uprichard; David J Perry
Journal:  Blood Rev       Date:  2002-06       Impact factor: 8.250

Review 9.  Recessively inherited coagulation disorders.

Authors:  Pier Mannuccio Mannucci; Stefano Duga; Flora Peyvandi
Journal:  Blood       Date:  2004-05-11       Impact factor: 22.113

  9 in total
  1 in total

1.  Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Authors:  Yushi Chikasawa; Keiko Shinozawa; Kagehiro Amano; Kyoichi Ogata; Takeshi Hagiwara; Takashi Suzuki; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.